Common Non-Stimulant Medications for ADHD

Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a licensed healthcare provider with any questions you may have regarding a mental health condition. If you are experiencing a medical emergency, please call 911 or your local emergency number immediately.

This information is provided for informational purposes for those who have been clinically diagnosed with ADHD and have questions about the range of treatment options available.  It is not intended to advocate any specific course of treatment. For those diagnosed with ADHD, a course of treatment should only be established in direct conjunction with a treating physician. 

Common Non Stimulant Medication for ADHD min 1 image

In many clinical settings, stimulant medications are often considered among the first options for managing ADHD symptoms, when appropriate and under the supervision of a licensed prescriber. Examples of stimulants are Adderall, Ritalin, Vyvanse, and Concerta. But for some people, stimulants aren’t the best option or may not be the treatment of choice. In these cases, non-stimulant medications may be considered as an alternative for managing ADHD symptoms, depending on individual needs and under clinical supervision.

Types of non-stimulants

Clinicians may prescribe or discuss several categories of non-stimulant medications as part of ADHD care, when warranted by diagnosis and specific patient circumstances. This range of non-stimulant options could include, based on the circumstances:

  • ADHD-specific non-stimulants
  • Antidepressants
  • Blood pressure medications

Who uses non-stimulants

Some people experience unpleasant or severe side effects when they take stimulants. Others have pre-existing health conditions, such as thyroid or heart issues, which means they may not react well to a stimulant. And others may have preferences for non-stimulants over stimulants for other reasons.  A patient should not make these determinations on their own, but only in collaboration with their treatment physician.

For example, some FDA-approved non-stimulants, such as Qelbree, have properties that may align with individual lifestyle or sleep-schedule needs, as determined by a healthcare provider. They can be taken at any time of day, and they don’t have the wakefulness side effect that many stimulants have.  The patient’s healthcare provider can determine what’s appropriate for the circumstances.

As another example, if a patient has a mood disorder along with ADHD, a non-stimulant may be a good choice. Another situation where a non-stimulant might be preferable is when the patient has been on stimulants, but doesn’t feel like they help. Or maybe they used to work, but they don’t seem to anymore, even after the patient has tried various kinds. In these cases, a physician may suggest that the patient try a non-stimulant medication or possibly add one to the stimulant, depending on the situation. 

Stimulants vs. non-stimulants

STIMULANTSNON-STIMULANTS
Often the first line of treatment for ADHD, although circumstances may varyOften the second or third line of treatment for ADHD, although circumstances may vary
Work for ~70% of people1Often considered for people who don’t tolerate or respond to stimulants
Work quicklyIt may take up to six weeks for the full effect
May wear off suddenlyEffects last longer
Risk of abuse or addictionGenerally, there is a lower risk of abuse or addiction. (Still, use of most should be tapered slowly and not discontinued abruptly.)
Can only be prescribed by a clinician when warranted, after a full diagnosis. Considered controlled substances, which can make them more challenging to obtain, especially when travelingCan only be prescribed by a clinician when warranted, after a full diagnosis. Not controlled substances

ADHD-specific non-stimulants

These non-stimulant medications are among those approved by the U.S. Food and Drug Administration specifically to treat ADHD. Note that this list may evolve over time. Note that all of these can only be prescribed by an appropriately licensed clinician when warranted by an ADHD diagnosis.

Strattera (atomoxetine)

Strattera (atomoxetine) is the first non-stimulant that the FDA approved for treating ADHD in 2002.

How it works: Norepinephrine is a chemical messenger in the brain called a neurotransmitter. It affects memory, sleep cycle, mood, attention, arousal, and alertness. Strattera is a norepinephrine reuptake inhibitor, or SNRI. That means it boosts the amount of norepinephrine in the brain. This mechanism is thought to influence symptoms such as hyperactivity and inattention.

Qelbree (viloxazine)

The FDA approved this non-stimulant for treating ADHD in adults in May 2022.

How it works: Like Strattera, Qelbree is an SNRI that increases the amount of norepinephrine in the brain. It may also be prescribed in some instances involving anxiety or depression, as determined by a healthcare provider.

Intuniv ER (guanfacine)

Intuniv ER is an extended-release medication that’s typically used to treat high blood pressure. It can be used alone or in addition to a stimulant.

How it works: Intuniv ER decreases adrenaline levels and can improve ADHD symptoms.

Kapvay ER (clonidine)

Kapvay ER is also an extended-release medication that’s typically used for high blood pressure. 

How it works: Kapvay ER reduces blood pressure and boosts norepinephrine in the brain. 

Antidepressants

Antidepressants are sometimes used to treat ADHD symptoms, especially if one has depression or anxiety along with ADHD. They’re usually not as effective as stimulants or ADHD-specific non-stimulants. But a stimulant might be added to these if the treating physician deems it is needed. Use of antidepressants for ADHD may be considered ‘off-label’ in certain cases; such decisions must be made by a licensed prescriber familiar with patient’s medical history.

Wellbutrin (bupropion) 

Wellbutrin (bupropion) is used to treat depression, help people stop smoking, and prevent depression in people with seasonal affective disorder, or SAD. It’s the most prescribed antidepressant for ADHD. 

How it works: Wellbutrin is a norepinephrine dopamine reuptake inhibitor, or NDRI. It increases the levels of the neurotransmitters dopamine and norepinephrine in your brain, which can decrease ADHD symptoms.

Effexor and Effexor XR (venlafaxine)

These are newer antidepressants that a doctor might prescribe for patients who have depression as well as ADHD.

How it works: Effexor is a serotonin-norepinephrine reuptake inhibitor, or SNRI. It boosts the neurotransmitters norepinephrine and serotonin in your brain, which can help your concentration and mood.

Tricyclic Antidepressants

Research has found that tricyclic antidepressants such as Pamelor (nortriptyline), Tofranil (imipramine), and Norpramin (desipramine) improve ADHD symptoms in some people. However, the side effects of these medications can be unpleasant. They’re considered a third-line treatment for ADHD.

Monoamine Oxidase Inhibitors, or MAOIs

A category of antidepressants called monoamine oxidase inhibitors, or MAOIs — particularly Nardil (phenelzine) and Parnate (tranylcypromine) — can help improve symptoms of ADHD. They’re not used very often, though, because they can have major side effects and serious interactions with other medications and certain foods.

Blood pressure medications

Tenex (guanfacine) and Catapres (clonidine) are sometimes used to treat ADHD. These are the immediate-release forms of the FDA-approved versions, though Tenex and Catapres aren’t technically approved for treating ADHD. These medications are sometimes prescribed ‘off-label’ for ADHD symptoms; off-label prescribing is at the clinician’s discretion based on individual clinical judgment.

The Physician Role is Critical in Identifying Best Treatment Paths

If a patient has already been diagnosed with ADHD, any course of treatment must be in conjunction with the treating physician. Patients considering changes to their ADHD medication should consult a licensed healthcare provider.  A patient might need a complete change, or may just need to add a non-stimulant to a regimen, but the treating physician would offer this guidance. 


Dr. Michele Musto min image

Clinically reviewed by Michele Musto, M.D., FAAFP. Dr. Michele Musto is a board-certified family medicine physician and Fellow of the American Academy of Family Physicians with more than two decades of experience in clinical practice and hospital medicine. She has served as a hospitalist, medical director, and educator, providing comprehensive care to patients across diverse healthcare settings. Dr. Musto completed her residency in Family Medicine at Mercer University School of Medicine and earned her Doctor of Medicine degree from the International University of the Health Sciences.

Barry K. Herman min image

Clinically reviewed by Barry K. Herman, M.D., M.M.M. Dr. Herman is a dual board-certified adult psychiatrist and child and adolescent psychiatrist with over three decades of experience in clinical practice, industry, digital health, and organized medicine leadership. He currently serves as Chief Medical Officer at Mentavi Health and has held senior medical and executive roles in the pharmaceutical industry and other leading organizations in digital health and therapeutics. Dr. Herman earned his M.D. from Tufts University School of Medicine and a Master of Medical Management from Tulane University.

The Expert Mental Health Care You Need Now

From ADHD to anxiety and beyond—we can help.
Start Your Assessment

Learn About ADHD Services in Your State

Live your best life with ADHD

Learn more about the three steps to Medical Treatment for ADHD
3 Simple Steps

More than ADHD?

From anxiety and depression to binge eating and obsessive compulsive disorder, ADHD rarely operates alone. Our Mentavi Diagnostic Evaluation screens for common comorbidities.
Learn More
Share:
Explore More

Misunderstood and undiagnosed: ADHD in BIPOC communities

Awareness and treatment of ADHD have increased steadily in recent years, with more people seeking diagnosis and treatment

Looking for Therapy? Here Are 5 Reasons to Choose a Doctorate-Level Psychologist

Choosing a psychologist offers distinct advantages, enhancing your therapy experience. Here are 5 reasons to select a doctorate-level

ADHD and anxiety medication: An exploration of treatment methods

An effective treatment plan is comprehensive, including pharmaceutical and non-pharmaceutical methods. Embracing a diverse approach to treatment can
Articles

The constant present: Time blindness and ADHD

“Where did the time go?” It’s a question that everyone asks from...
Podcasts

Part Two: ADHD and Time Blindness with Dr. Ari Tuckman

Today, we’re continuing our conversation with Dr. Ari Tuckman, exploring...
Webinars

Mentavi Holiday Mental Wellness Series

Join us to find calm in the chaos and build...

Curious about stimulant or non-stimulant approaches?

If you’re navigating ADHD or other mental health challenges, you have options. At Mentavi Health / ADHD Online, we assess what works for you. 
Some may start with non-medicated approaches like coaching or therapy.  In other cases, patients may explore medication treatment paths when warranted by diagnosis. For some diagnosed with ADHD, the treatment clinician may work with the patient to determine if stimulant approaches work best for them. Stimulant approaches are certain medications under medical treatment that are generally Class II controlled substances. Non-stimulant options are another approach that can work for many.  Medication approaches can be used in tandem with coaching or therapy. 
 
The key is starting with our diagnostic evaluation, which is reviewed by a qualified healthcare professional. Getting clarity on what you’re experiencing is the first step toward feeling more in control. From there, you and your treatment team can determine the best path—whether that’s coaching, therapy, medication, or a combination that works for your life. 
 
If you’re not feeling right, let us walk alongside you by starting with the diagnostic evaluation.
There may be a brief delay in service today between 12:30 PM and 1:30 PM ET. Thank you for your patience — we look forward to assisting you shortly.
 
The ADHD Online Team

Join Our ADHD Research Study

Mentavi Health is conducting ADHD research and is accepting a limited number of participants. Participants in our clinical study will get an ADHD Assessment at no cost. 

Who can join?
  • Age 19+
  • Primary language is English
  • Not previously diagnosed with ADHD
  • Not a current patient of ADHD Online or Mentavi Health
  • A resident of any of the 50 US states or DC (not including Puerto Rico or other territories)
 
Why participate?
Your involvement will help improve mental health care for everyone.
 

HOLIDAY HOURS

ADHD Online will be closed on Thursday, December 25, and Friday, December 26, as well as Thursday, January 1, in observance of the holidays.

Live support will be unavailable during this time; however, you can still submit a request or leave a message. We’ll get back to you when we return.

Each of our clinicians sets their own holiday hours, check with them for their availability.

Are you looking to take our Diagnostic Evaluation? It’s available all day, every day, whenever and wherever is best for you! 

Our site is open 24/7! You can always schedule an appointment, check out our recorded webinars, or read up on the latest mental health information.

Provide this form to your local practitioner. You could:

  • Send this link
  • Email the pdf
  • Print it out and bring it to your appointment

Ask your practitioner
to complete the form

In this form, your practitioner will request that ADHD Online continue to provide uninterrupted care

Return the form to us

You or your practitioner can return this form to us via email or fax it to 616-210-3118